Skip to main content
. 2022 Dec 14;29(12):9855–9866. doi: 10.3390/curroncol29120774

Figure 1.

Figure 1

The flowchart shows the inclusion and exclusion process of the study patients. HCC: hepatocellular carcinoma; TACE: transarterial chemoembolization; TAA: tumor active area.